Logo image of AXLA

AXCELLA HEALTH INC (AXLA) Stock Analyst Ratings

USA - NASDAQ:AXLA - US05454B2043 - Common Stock

4.58 USD
-0.9 (-16.42%)
Last: 11/22/2023, 8:00:01 PM
3.42 USD
-1.16 (-25.33%)
After Hours: 11/22/2023, 8:00:01 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to AXLA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 15870.09. This target is 346408.54% above the current price.
AXLA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AXLA.
In the previous month the buy percentage consensus was at a similar level.
AXLA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

AXLA Historical Analyst RatingsAXLA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -53 -48 -43 -38 -33 -28 -23 -18 -13 -8 -3 5 10 15

Price Target & Forecast

Price Low Median Mean High 4.58860.0915,870.0915,870.0931,779.56 - 18,679.28% 346,408.54% 346,408.54% 693,776.90%

Related screens

AXLA Current Analyst RatingAXLA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-02-16 HC Wainwright & Co. Maintains Neutral
2022-12-16 SVB Leerink Downgrade Outperform -> Market Perform
2022-12-15 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-11-02 Chardan Capital Maintains Buy
2022-10-03 HC Wainwright & Co. Maintains Buy
2022-08-03 SVB Leerink Maintains Outperform
2022-08-03 HC Wainwright & Co. Maintains Buy
2022-05-09 Chardan Capital Maintains Buy
2021-11-16 Chardan Capital Maintains Buy
2021-10-12 Noble Capital Markets Initiate Outperform
2021-09-22 Goldman Sachs Downgrade Buy -> Neutral
2021-07-30 JP Morgan Downgrade Neutral -> Underweight
2021-07-06 HC Wainwright & Co. Initiate Buy
2021-06-03 Chardan Capital Maintains Buy

AXCELLA HEALTH INC / AXLA FAQ

What is the average price target for AXCELLA HEALTH INC (AXLA) stock?

8 analysts have analysed AXLA and the average price target is 15870.1 USD. This implies a price increase of 346408.73% is expected in the next year compared to the current price of 4.58.


What is the consensus rating for AXCELLA HEALTH INC (AXLA) stock?

The consensus rating for AXCELLA HEALTH INC (AXLA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.